Patterson Companies (PDCO) Stock Price, News & Analysis

Company Overview

Patterson Companies, Inc. (NASDAQ: PDCO) is a leading distributor of dental and animal health products and equipment, headquartered in St. Paul, Minnesota. Founded in 1878, the company has evolved into two primary business segments—Patterson Dental and Patterson Veterinary—serving a broad network of dental, veterinary and livestock customers across the United States and Canada. Through a combination of product sales, equipment service and integrated technology solutions, Patterson Companies supports clinical practices of all sizes.

The Patterson Dental segment provides dental professionals with a comprehensive portfolio of consumables, capital equipment, imaging systems and digital dentistry solutions. Offerings include dental chairs, imaging sensors and software platforms for practice management, digital impressioning and 3D printing. Patterson Dental’s distribution centers and sales teams help practices optimize workflows, enhance patient care and manage inventory, backed by technical support and training programs.

Under Patterson Veterinary, the company delivers pharmaceuticals, vaccines, instruments, laboratory equipment and practice management software to companion animal, equine and livestock veterinary practices. The segment’s product mix spans in-office diagnostic testing, surgical instruments and large-animal care solutions, while its field service specialists provide installation, maintenance and training. Patterson Veterinary aims to streamline clinical operations and improve animal health outcomes through tailored supply chain and technology offerings.

Over its long history, Patterson Companies has grown both organically and through targeted acquisitions, broadening its geographic reach and product capabilities. Under the leadership of President and Chief Executive Officer Nipun V. Firodia, the company emphasizes customer service, operational efficiency and investment in digital innovations. With multiple distribution centers and a large team of field representatives, Patterson Companies continues to support the evolving needs of dental and veterinary professionals across North America.

Key Stats

• Today's Range: $31.33 to $31.33
• 50-Day Range: $31.33 to $31.33
• 52-Week Range: $19.45 to $31.79
• Volume: N/A
• Average Volume: 1.28 million shs
• Market Capitalization: $2.77 billion
• P/E Ratio: 18.32
• Dividend Yield: 3.32%
• Price Target: $26.57
• Consensus Rating: Hold

Patterson Companies Stock Analysis - MarketRank™

Patterson Companies scored higher than 29% of companies evaluated by MarketBeat, and ranked 810th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Patterson Companies has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on 1 buy rating, 10 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Patterson Companies has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.44%

Earnings Growth

Earnings for Patterson Companies are expected to grow by 8.44% in the coming year, from $2.25 to $2.44 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Patterson Companies is 18.32, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.86.

Price to Earnings Ratio vs. Sector

The P/E ratio of Patterson Companies is 18.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.26.

Price to Earnings Growth Ratio

Patterson Companies has a PEG Ratio of 2.71. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Patterson Companies has a P/B Ratio of 2.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for PDCO.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Patterson Companies pays a meaningful dividend of 3.34%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Patterson Companies does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Patterson Companies is 67.53%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Patterson Companies will have a dividend payout ratio of 42.62% next year. This indicates that Patterson Companies will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 1.7 / 5
• Environmental Score: -1.36

Short Interest

There is no current short interest data available for PDCO.

News and Social Media

• Score: 0.5 / 5
• News Sentiment: -1.05

News Sentiment

Patterson Companies has a news sentiment score of -1.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.00 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Patterson Companies this week, compared to 8 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Patterson Companies insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.90% of the stock of Patterson Companies is held by insiders.

Percentage Held by Institutions

85.43% of the stock of Patterson Companies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

PDCO Stock Analysis - Frequently Asked Questions

How have PDCO shares performed this year?

Patterson Companies' stock was trading at $30.86 at the beginning of 2025. Since then, PDCO stock has increased by 1.5% and is now trading at $31.33.

How were Patterson Companies' earnings last quarter?

Patterson Companies, Inc. (NASDAQ:PDCO) released its quarterly earnings results on Thursday, December, 5th. The company reported $0.47 earnings per share for the quarter, missing analysts' consensus estimates of $0.49 by $0.02. Patterson Companies's revenue was up 1.0% compared to the same quarter last year.
Read the conference call transcript.

Who are Patterson Companies' major shareholders?

Patterson Companies' top institutional shareholders include Rowlandmiller & PARTNERS.ADV. Insiders that own company stock include Donald Zurbay, Kevin Michael Barry and Timothy E Rogan.
View institutional ownership trends.

How do I buy shares of Patterson Companies?

Shares of PDCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Patterson Companies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Patterson Companies investors own include American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR) and Humana (HUM).

Company Calendar

• Last Earnings: 12/05/2024
• Today: 7/13/2025
• Next Earnings (Estimated): 8/26/2025
• Fiscal Year End: 4/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical & hospital equipment
• Sub-Industry: Health Care Distributors
• Current Symbol: NASDAQ:PDCO
• CIK: 891024
• Web: www.pattersoncompanies.com
• Phone: (651) 686-1600
• Fax: 651-686-9331
• Employees: 7,700
• Year Founded: 1877

Price Target and Rating

• Average Price Target for Patterson Companies: $26.57
• High Price Target: $31.35
• Low Price Target: $22.00
• Potential Upside/Downside: -15.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.09
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.54
• Trailing P/E Ratio: 18.32
• Forward P/E Ratio: 13.92
• P/E Growth: 2.71
• Net Income: $185.93 million
• Net Margins: 2.37%
• Pretax Margin: 3.09%
• Return on Equity: 19.77%
• Return on Assets: 6.66%

Debt

• Debt-to-Equity Ratio: 0.34
• Current Ratio: 1.37
• Quick Ratio: 0.76

Sales & Book Value

• Annual Sales: $6.51 billion
• Price / Sales: 0.43
• Cash Flow: $3.42 per share
• Price / Cash Flow: 9.17
• Book Value: $11.18 per share
• Price / Book: 2.80

Miscellaneous

• Outstanding Shares: 88,474,000
• Free Float: 86,638,000
• Market Cap: $2.77 billion
• Optionable: Optionable
• Beta: 0.73